Article
Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin
12 Sept 2023
Abstract excerpt
OBJECTIVES: Fosfomycin is a first-line treatment for uncomplicated urinary tract infections (UTIs) in several European countries, and it is increasingly becoming the treatment of choice globally. Resistance to fosfomycin in Escherichia coli can be exerted through several mechanisms, including the acquisition of fosfomycin-modifying enzymes, of which the FosA-type enzymes are the most common. This study analysed,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
